These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 18445837)
1. Will we ever be ready for blood level-guided therapy? Walko CM; McLeod HL J Clin Oncol; 2008 May; 26(13):2078-9. PubMed ID: 18445837 [No Abstract] [Full Text] [Related]
2. Individual fluorouracil dose adjustment based on pharmacokinetic follow-up compared with conventional dosage: results of a multicenter randomized trial of patients with metastatic colorectal cancer. Gamelin E; Delva R; Jacob J; Merrouche Y; Raoul JL; Pezet D; Dorval E; Piot G; Morel A; Boisdron-Celle M J Clin Oncol; 2008 May; 26(13):2099-105. PubMed ID: 18445839 [TBL] [Abstract][Full Text] [Related]
3. Limited sampling model for the analysis of 5-fluorouracil pharmacokinetics in adjuvant chemotherapy for colorectal cancer. Di Paolo A; Danesi R; Vannozzi F; Falcone A; Mini E; Cionini L; Ibrahim T; Amadori D; Del Tacca M Clin Pharmacol Ther; 2002 Dec; 72(6):627-37. PubMed ID: 12496744 [TBL] [Abstract][Full Text] [Related]
4. Dose and time dependencies of 5-fluorouracil pharmacokinetics. Terret C; Erdociain E; Guimbaud R; Boisdron-Celle M; McLeod HL; Féty-Deporte R; Lafont T; Gamelin E; Bugat R; Canal P; Chatelut E Clin Pharmacol Ther; 2000 Sep; 68(3):270-9. PubMed ID: 11014408 [TBL] [Abstract][Full Text] [Related]
5. [Cytoreductive surgery as an alternative to palliative operations in oncology (the model of treatment of stage IV colorectal cancer)]. Grinev MV Vestn Khir Im I I Grek; 2002; 161(6):100-3. PubMed ID: 12638509 [TBL] [Abstract][Full Text] [Related]
6. [Concentrations of 5-fluorouracil (5-FU) in serum and tissues at venous injection of tegafur or 5-FU--clinical study on colorectal cancer]. Kojima T; Suzumura K; Kanemitsu T; Miyashita A; Inamura Y; Owa Y; Naruse T Gan To Kagaku Ryoho; 1998 Mar; 25(4):547-51. PubMed ID: 9530361 [TBL] [Abstract][Full Text] [Related]
7. [Therapeutic drug monitoring of 5-fluorouracil after its administration in high-dose protocols]. Boisdron-Celle M; Le Guellec C; Therapie; 2010; 65(3):171-6. PubMed ID: 20699067 [TBL] [Abstract][Full Text] [Related]
8. Determining the optimal 5-FU therapeutic dosage in the treatment of colorectal cancer patients. Fang L; Jiang Y; Yang Y; Zheng Y; Zheng J; Jiang H; Zhang S; Lin L; Zheng J; Zhang S; Zhuang X Oncotarget; 2016 Dec; 7(49):81880-81887. PubMed ID: 27636992 [TBL] [Abstract][Full Text] [Related]
9. [Biochemical modulation by leucovorin of the antineoplastic effect of fluorofur in disseminated colorectal cancer]. Manziuk LV; Perevodchikova NI; Gorbunova VA; Luk'ianchenko AB; Abramova NA Vopr Onkol; 1996; 42(3):33-6. PubMed ID: 8801738 [No Abstract] [Full Text] [Related]
10. The dead end of 5-fluorouracil double modulation and promise of continuous infusion schedules in the treatment of metastatic colorectal cancer. Köhne CH; Wilke H; Schöffski P; Schmoll HJ J Infus Chemother; 1996; 6(4):206-10. PubMed ID: 9229317 [No Abstract] [Full Text] [Related]
11. Pharmacokinetic adaptation of 5-fluorouracil: where are we and where are we going? Boisdron-Celle M Pharmacogenomics; 2012 Oct; 13(13):1437-9. PubMed ID: 23057541 [No Abstract] [Full Text] [Related]
12. [Anaphylactoid shock due to folinic acid during treatment of metastatic colorectal cancer]. Benoit R; Grobost O; Chalmet P Gastroenterol Clin Biol; 2000 Dec; 24(12):1241-2. PubMed ID: 11173744 [No Abstract] [Full Text] [Related]
13. [Modeling 5-FU clearance during a chronomodulated infusion]. Kwiatkowski F; Chevalier V; Chevrier R; Richard D; Cure H; Chollet P Pathol Biol (Paris); 2003 Jun; 51(4):231-3. PubMed ID: 12852999 [TBL] [Abstract][Full Text] [Related]
15. Clinical Benefit of Therapeutic Drug Monitoring in Colorectal Cancer Patients Who Received Fluorouracil-Based Chemotherapy. Zhou X; Chang Y; Qian J; Shen C; Han J; Zhao H; Chang R Med Sci Monit; 2021 Jul; 27():e929474. PubMed ID: 34330885 [TBL] [Abstract][Full Text] [Related]
16. Influence of the administration of amifostine on the pharmacokinetics of 5-fluorouracil in patients with metastatic colorectal carcinoma. Martens-Lobenhoffer J; Fuhlroth J; Ridwelski K Int J Clin Pharmacol Ther; 2000 Jan; 38(1):41-4. PubMed ID: 10667836 [TBL] [Abstract][Full Text] [Related]
18. 5-fluorouracil pharmacokinetics predicts disease-free survival in patients administered adjuvant chemotherapy for colorectal cancer. Di Paolo A; Lencioni M; Amatori F; Di Donato S; Bocci G; Orlandini C; Lastella M; Federici F; Iannopollo M; Falcone A; Ricci S; Del Tacca M; Danesi R Clin Cancer Res; 2008 May; 14(9):2749-55. PubMed ID: 18451241 [TBL] [Abstract][Full Text] [Related]
19. Individual 5-Fluorouracil Dose Adjustment via Pharmacokinetic Monitoring Versus Conventional Body-Area-Surface Method: A Meta-Analysis. Yang R; Zhang Y; Zhou H; Zhang P; Yang P; Tong Q; Lyu Y; Han Y Ther Drug Monit; 2016 Feb; 38(1):79-86. PubMed ID: 26309030 [TBL] [Abstract][Full Text] [Related]
20. A patient with a prolonged prothrombin time due to an adverse interaction between 5-fluorouracil and warfarin. Aki Z; Kotiloğlu G; Ozyilkan O Am J Gastroenterol; 2000 Apr; 95(4):1093-4. PubMed ID: 10763974 [No Abstract] [Full Text] [Related] [Next] [New Search]